公司資料

Palatin Technologies, Inc. 股價、新聞與催化劑

股票代碼:
PTN
交易所:
NASDAQ
產業:
Biopharma
所在地:
United States

股票表現

9.95 USD (+6.30%)

收盤價

最後更新: 2026年8月17日

24.7M USD

市值

股價為何變動

As of Aug 17, 2026, PTN closed up 6.30% at $9.95. No new same-company headline was identified in the current news window.

公司概覽

業務概覽

Palatin Technologies is a specialty pharmaceutical company focused on receptor biology and niche therapeutic areas. Its story has centered on a small set of programs and the difficulty of sustaining a durable commercial or development base.

所在地與產業分類

Palatin is headquartered in the United States and listed on NYSE American. It sits in specialty pharma rather than broad biotech.

商業模式特徵

The company depends on clinical progress, commercial execution, and capital discipline. Investors typically watch pipeline updates and strategic positioning.

生技產業定位

Palatin occupies a small specialty-pharma niche within healthcare. It is a catalyst-sensitive story where a narrow set of programs can dominate the valuation.

未來催化劑

  • Palatin’s catalysts are obesity and women’s-health programs, especially any development or partnering step that keeps the pipeline relevant. The company still needs a clearer path to value.

近期新聞

    相似股票

    商業成熟度、治療領域或催化劑模式相近的同業公司。